Kefir for Antimicrobial Properties

Research suggests that kefir and its constituent microorganisms demonstrate a broad range of antimicrobial properties across multiple laboratory and animal studies, with evidence pointing to several distinct mechanisms including the production of bioactive peptides, exopolysaccharides, novel sugar-amino acid complexes, and direct pathogen inhibition by specific bacterial and yeast strains. Studies indicate that isolated kefir microorganisms — including Lactobacillus species, Bacillus species, and kefir-derived yeasts such as Kluyveromyces marxianus — can inhibit both Gram-positive and Gram-negative pathogens, with one 2020 study reporting that a novel kefir-derived fraction was capable of killing antibiotic-resistant MRSA and Pseudomonas aeruginosa and enhancing the effectiveness of an existing antibiotic fivefold in laboratory conditions. The available evidence consists primarily of in vitro studies and a small number of animal experiments, with no randomized controlled trials in humans identified among the reviewed literature, and a 2022 review noted that most research has focused on individual microbial strains rather than the full kefir microbial community, leaving the precise mechanisms and real-world relevance of these effects poorly understood. Overall, the body of evidence is directionally supportive but largely preliminary, and further human studies would be needed to determine whether the antimicrobial activity observed in laboratory settings translates to meaningful health outcomes.